Skip to content

ADVB

Advanced Biomed, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$2.30
−12.88%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue127.6K127.6K———
Cost of Revenue5.0M6.4M———
Gross Profit(4.9M)(6.2M)———
Operating Expenses
R&D Expense665.5K—909.8K880.2K1.4M
SG&A Expense747.5K—2.1M1.7M1.7M
General & Admin Expense747.5K—2.1M1.7M1.7M
Selling & Marketing Expense—————
Other Expenses27.3K————
Total Operating Expenses1.4M—3.0M2.5M3.1M
Cost and Expenses6.5M6.4M3.0M2.5M3.1M
Operating Income (EBIT)(6.4M)(6.2M)(3.0M)(2.5M)(3.1M)
Non-Operating
Interest Income9.7K—24.9K53.5K21.4K
Interest Expense7.1K7.0K———
Net Interest Income2.5K(7.0K)24.9K53.5K21.4K
Other Non-Op Income/Expense(28.1K)(28.9K)(237.9K)(240.7K)(661.6K)
Non-Operating Income (excl Interest)158.0K21.9K237.9K240.7K661.6K
EBT (Pre-Tax Income)(6.4M)(6.3M)(3.3M)(2.8M)(3.7M)
Income Tax Expense(1.2K)(1.2K)———
Bottom Line
Net Income6.7M6.7M(3.3M)(2.8M)(3.7M)
Earnings from Cont. Ops(6.4M)(6.3M)(3.3M)(2.8M)(3.7M)
Earnings from Discont. Ops13.1M12.9M———
Bottom Line Net Income6.7M6.7M(3.3M)(2.8M)(3.7M)
Per Share
Basic EPS$0.47$5.33($0.16)($0.14)($0.19)
Diluted EPS$0.47$5.33($0.16)($0.14)($0.19)
Revenue Per Share$0.10$0.10$0.00$0.00$0.00
Shares
Basic Shares Outstanding1.3M1.3M20.5M20.0M19.9M
Diluted Shares Outstanding1.3M1.3M20.5M20.0M19.9M
Profitability Metrics
EBITDA(6.4M)(6.3M)(2.9M)(2.4M)(3.4M)
D&A71.8K—343.8K399.6K365.2K
EBIT(6.5M)(6.3M)(3.3M)(2.8M)(3.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026